MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Awakn Life Sciences Corp (OP:AWKNF)

0.0650 UNCHANGED
Last Price Updated: 3:11 PM EST, Dec 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0650
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0650
Today's Range 0.0650 - 0.0650
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Shuttle Pharma Ramps Up Fight Against Glioblastoma With New Leadership, Promising Clinical Trial, and Bold Innovations ↗
Via Stocktwits
Topics Cannabis
News headline image
Awakn Partners With University Of Nottingham For Preclinical Testing Of Psychoactive Therapy ↗
Awakn Life Sciences partners with the University of Nottingham to advance in vivo testing of its aminoindane therapy for PTSD, with results expected by late 2024. 
Via Benzinga

Performance

More News

Read More
News headline image
Investors Back Awakn's Psychedelic Therapies, As Company Doubles Private Placement To $2M ↗
Via Benzinga
News headline image
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More ↗
Via Benzinga
News headline image
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More ↗
Via Benzinga
News headline image
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More ↗
Via Benzinga
News headline image
Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More ↗
Via Benzinga
News headline image
Awakn Life Sciences Enters Into Global Licensing Agreement For Sublingual Delivery Formulation ↗
Via Benzinga
News headline image
Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More ↗
Via Benzinga
Topics Cannabis
News headline image
UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center ↗
Via Benzinga
News headline image
U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy ↗
Via Benzinga
News headline image
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Awakn Life Sciences Submits CTA For Phase III Alcohol Use Disorder Clinical Trial ↗
Via Benzinga
News headline image
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More ↗
Via Benzinga
News headline image
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More ↗
Via Benzinga
News headline image
Awakn Life Sciences Becomes Pure R&D Biotech After Sale Of Norway Clinics ↗
Via Benzinga
News headline image
Awakn Life Sciences On Track With Phase 3 Trial To Research Substance Use Disorder ↗
Via Benzinga
News headline image
Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More ↗
Via Benzinga
News headline image
Awakn Life Sciences Sells London Clinics Business, Hopes To Divest Norwegian Unit Next ↗
Via Benzinga
News headline image
Awakn Life Sciences Announces Closing Of Second Tranche And Upsizing Of Previous Private Placement ↗
Via Benzinga
News headline image
Awakn To Focus On R&D Of Addiction Therapies, Moves Away From Ketamine Treatment For Alcoholism ↗
Via Benzinga
News headline image
Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More ↗
Via Benzinga
News headline image
Awakn's Q4 2023 And Annual Financials, +500% YoY Revenue Increase Following Network Expansion ↗
Via Benzinga
News headline image
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More ↗
Via Benzinga
News headline image
Severe Alcohol Use Disorder Patients Will Try Ketamine Therapy At Awakn's New Phase 3 Study ↗
Via Benzinga

Frequently Asked Questions

Is Awakn Life Sciences Corp publicly traded?
Yes, Awakn Life Sciences Corp is publicly traded.
What exchange does Awakn Life Sciences Corp trade on?
Awakn Life Sciences Corp trades on the OTC Traded
What is the ticker symbol for Awakn Life Sciences Corp?
The ticker symbol for Awakn Life Sciences Corp is AWKNF on the OTC Traded
What is the current price of Awakn Life Sciences Corp?
The current price of Awakn Life Sciences Corp is 0.0650
When was Awakn Life Sciences Corp last traded?
The last trade of Awakn Life Sciences Corp was at 12/13/24 03:11 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story